Flare Therapeutics is pioneering the field of drug discovery by focusing on transcription factors. The company aims to revolutionize disease treatment through its unique discovery engine that combines genetic, biochemical, and chemical insights to identify druggable pockets in transcription factors. Flare Therapeutics is initially targeting precision oncology, developing small molecules to restore transcriptional control disrupted by cancer.
September 16
Lead cheminformatics and machine learning initiatives at Flare Therapeutics.